6aminocaproic acid

6-Aminocaproic acid (EACA) is an antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.

6-Aminocaproic acid-(S,R,S)-AHPC-Me serves as a ligand and linker for the E3 ubiquitin ligase in PROTACs, facilitating the synthesis of PVD-06 for research in oncology.

6-Aminocaproic acid hydrochloride, a monoamino carboxylic acid derivative, is a potent, orally active antifibrinolytic agent that inhibits plasmin and plasminogen. It competitively binds to lysine residues on plasminogen, preventing clot lysis by inhibiting plasmin formation and reducing fibrinolysis. This compound is utilized in researching bleeding disorders.

6-Aminocaproic acid-d6 is the deuterated form of 6-Aminocaproic acid (EACA), a monoamino carboxylic acid. This compound acts as an effective and orally active inhibitor of plasmin and plasminogen. It serves as a potent antifibrinolytic agent by competitively binding to lysine residues on plasminogen, preventing clot dissolution, inhibiting plasmin formation, and reducing fibrinolysis. Additionally, 6-Aminocaproic acid is utilized in the study of hemorrhagic disorders.

6-Aminocaproic acid (Standard) is the standard substance of 6-Aminocaproic acid, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. 6-Aminocaproic acid (EACA) is an antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.